Chloride extrusion enhancers as novel therapeutics for neurological diseases

被引：0
|
作者：
Martin Gagnon
Marc J Bergeron
Guillaume Lavertu
Annie Castonguay
Sasmita Tripathy
Robert P Bonin
Jimena Perez-Sanchez
Dominic Boudreau
Bin Wang
Lionel Dumas
Isabelle Valade
Karine Bachand
Mariève Jacob-Wagner
Christian Tardif
Irenej Kianicka
Paul Isenring
Giorgio Attardo
Jeffrey A M Coull
Yves De Koninck
机构：
[1] Institut Universitaire en Santé Mentale de Québec,Department of Psychiatry & Neuroscience
[2] Université Laval,undefined
[3] Chlorion Pharma,undefined
[4] Graduate Program in Biophotonics,undefined
[5] Université Laval,undefined
[6] Centre de Recherche du Centre Hospitalier Universitaire de Québec,undefined
来源：
Nature Medicine | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Dysfunction of the potassium-chloride cotransporter KCC2 has been linked to many neurological diseases, including pain, anxiety and epilepsy. Now, Yves De Koninck and his colleagues report that they have developed a novel small-molecule compound that is orally bioavailable and can activate KCC2 and reduce chronic pain in rats.
引用
收藏
页码：1524 / 1528
页数：4
相关论文
共 50 条
  • [41] Investigation of novel chemical scaffolds targeting prolyl oligopeptidase for neurological therapeutics
    Kumar, Raj
    Parameswaran, Saravanan
    Bavi, Rohit
    Baek, Ayoung
    Son, Minky
    Rampogu, Shailima
    Park, Chanin
    Lee, Gihwan
    Zeb, Amir
    Parate, Shraddha
    Rana, Rabia Mukhtar
    Lee, Keun Woo
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2019, 88 : 92 - 103
  • [42] Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics
    Perinelli, Diego Romano
    Vllasaliu, Driton
    Bonacucina, Giulia
    Come, Benedetta
    Pucciarelli, Stefania
    Ricciutelli, Massimo
    Cespi, Marco
    Itri, Rosangela
    Spinozzi, Francesco
    Palmieri, Giovanni Filippo
    Casettari, Luca
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 119 : 419 - 425
  • [43] Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
    Maramai, Samuele
    Gemma, Sandra
    Brogi, Simone
    Campiani, Giuseppe
    Butini, Stefania
    Stark, Holger
    Brindisi, Margherita
    FRONTIERS IN NEUROSCIENCE, 2016, 10
  • [44] MicroRNA Therapeutics in Neurological Disease
    Greenberg, David S.
    Soreq, Hermona
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (38) : 6022 - 6027
  • [45] Neurological and psychiatric therapeutics.
    Charpentier, Rene
    ANNALES MEDICO-PSYCHOLOGIQUES, 1945, 2 (03): : 322 - 323
  • [46] Monoclonal Antibodies as Neurological Therapeutics
    Gklinos, Panagiotis
    Papadopoulou, Miranta
    Stanulovic, Vid
    Mitsikostas, Dimos D.
    Papadopoulos, Dimitrios
    PHARMACEUTICALS, 2021, 14 (02) : 1 - 31
  • [47] Antioxidant polymeric nanoparticles as novel therapeutics for airway inflammatory diseases
    Yoo, Donghyuck
    Guk, Kyeonghye
    Kim, Hyungmin
    Khang, Gilson
    Wu, Dongmei
    Lee, Dongwon
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 450 (1-2) : 87 - 94
  • [48] Intracellular Chloride Channels: Novel Biomarkers in Diseases
    Rao, Shubha Gururaja
    Patel, Nee J.
    Singh, Harpreet
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [49] Fibroblast: A Novel Target for Autoimmune and Inflammatory Skin Diseases Therapeutics
    Chen, Xiaoyun
    Wu, Yutong
    Jia, Sujie
    Zhao, Ming
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2024, 66 (03) : 274 - 293
  • [50] Novel bile acid therapeutics for the treatment of chronic liver diseases
    Hegade, Vinod S.
    Speight, R. Alexander
    Etherington, Rachel E.
    Jones, David E. J.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (03) : 376 - 391
12345